|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008949830 |
| 003 |
SK-MaSNL |
| 005 |
20260304145419.0 |
| 008 |
250505c2005 xo fr|p|||||||000 b|slo |
| 015 |
|
|
|a SNBRB2007/02
|
| 035 |
|
|
|a (sysno)vtls008949830
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab7d3r
|
| 035 |
|
|
|a (uuid)716e2328-1a01-454a-befb-d341a618c198
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a07lo8
|
| 038 |
|
|
|a SNKBUCL
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.12-008.33-085
|2 2001
|
| 080 |
|
|
|a 615.22
|2 2001
|
| 245 |
0 |
0 |
|a CoaprovelR irbesartanum, hydrochlorthiazidum
|
| 300 |
|
|
|b Obr.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a farmakoterapia
|2 SNKPH
|9 14158
|
| 650 |
0 |
7 |
|a CoaprovelR (liek)
|2 SNK
|9 1468188
|
| 650 |
0 |
7 |
|a irbesartanum
|2 SNK
|9 1468189
|
| 650 |
0 |
7 |
|a hydrochlórtiazid
|2 SNK
|9 1309444
|
| 650 |
0 |
7 |
|a esenciálna hypertenzia
|2 SNKPH
|9 133054
|
| 773 |
0 |
|
|t Medinews
|g Roč. 3, č. 1 (2005), s. 8-9
|x 1336-3239
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 954 |
|
|
|a odborná, vedecká literatúra pôvodná (slovenská)
|2 lita
|
| 958 |
|
|
|a article2022
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a EUIPO
|
| 999 |
|
|
|c 2935513
|d 2937443
|
